How effective is immunotherapy for liver cancer?

Immunotherapy helps the immune system recognise and attack cancer cells. In liver cancer, the expected benefit is judged by scans, symptoms, liver blood tests and how well treatment can be continued. Some tumours shrink; others may stop growing for a period, while some do not respond. A scan can also look different when immune cells gather around a tumour, so your team interprets results over time rather than relying on one image.

The decision is shaped by the cancer’s extent and by the liver’s remaining reserve. Cirrhosis, hepatitis, autoimmune disease, transplant history and medicines that suppress immunity can change whether treatment is suitable. Immunotherapy may be used alone or with another systemic treatment, depending on the diagnosis and treatment plan.

Ask the oncology team how the cancer will be monitored and which result would count as benefit. Review liver function, viral hepatitis status, transplant considerations, autoimmune conditions and all medicines before the first dose. Tell the team promptly about new diarrhoea, rash, cough, breathlessness, yellowing of the skin, dark urine, unusual fatigue or abdominal pain; these can signal immune-related inflammation or a liver problem and may need assessment.

Seek urgent medical help for severe breathlessness, chest pain, confusion, fainting, vomiting that prevents fluids, rapidly worsening yellow skin or eyes, black stools, or heavy bleeding. Contact your cancer team quickly for fever, persistent diarrhoea, a spreading rash, marked weakness or a sudden change in abdominal swelling. Do not stop or delay a prescribed treatment without speaking with the team, unless emergency clinicians advise otherwise.

Which type and stage of liver cancer do I have, and what benefit is realistic for my situation? How will you assess response if the scan is unclear? How might cirrhosis, hepatitis or transplant history affect treatment? Which symptoms should make me call the team the same day? What alternatives are available if immunotherapy is unsuitable or stops helping?